Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -3.21% is 70% above its 5-year average of -10.69%, near the high end of its 5-year range (-26.04%–-3.21%).
As of the fiscal period ended Tuesday, June 30, 2026. 41.11% above its 12-month average of -5.45%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -3.21%.
RETURN ON INVESTED CAPITAL (ROIC)
-3.21%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-5.45%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-6.74%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-10.69%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-24.35%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-27.90%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-37.50%
CURRENT VS TTM AVG
+41.11%
CURRENT VS 3Y AVG
+52.38%
CURRENT VS 5Y AVG
+69.96%
CURRENT VS 10Y AVG
+86.82%
CURRENT VS 15Y AVG
+88.49%
CURRENT VS 20Y AVG
+91.44%
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
+91.00%
vs the sector median at left
Oramed Pharmaceuticals Inc.
Market Cap
$179.26M
Return on Invested Capital (ROIC)
-3.21%
TTM Avg
-5.45%
3Y Avg
-6.74%
5Y Avg
-10.69%
Market Cap
$179.75M
Return on Invested Capital (ROIC)
-46.59%
TTM Avg
-39.23%
3Y Avg
-33.74%
5Y Avg
-53.74%
Market Cap
$180.47M
Return on Invested Capital (ROIC)
-9.57%
TTM Avg
-477.38%
3Y Avg
-295.61%
5Y Avg
-295.61%
Market Cap
$182.60M
Return on Invested Capital (ROIC)
-51.01%
TTM Avg
-69.12%
3Y Avg
-59.60%
5Y Avg
-89.29%
Market Cap
$174.27M
Return on Invested Capital (ROIC)
-90.33%
TTM Avg
-95.47%
3Y Avg
-83.14%
5Y Avg
-82.51%
Market Cap
$173.76M
Return on Invested Capital (ROIC)
-42.61%
TTM Avg
-32.20%
3Y Avg
-32.84%
5Y Avg
-32.70%
Market Cap
$172.42M
Return on Invested Capital (ROIC)
-8.34%
TTM Avg
4.10%
3Y Avg
3.63%
5Y Avg
7.54%
Market Cap
$171.13M
Return on Invested Capital (ROIC)
-30.23%
TTM Avg
-28.70%
3Y Avg
-31.34%
5Y Avg
-41.69%
Market Cap
$169.53M
Return on Invested Capital (ROIC)
-5.22%
TTM Avg
-22.12%
3Y Avg
-29.09%
5Y Avg
-27.39%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oramed Pharmaceuticals Inc. (ORMP) | $179.26M | -3.21% | -5.45% | -6.74% | -10.69% |
| Compass Therapeutics, Inc. (CMPX)vs › | $179.75M | -46.59% | -39.23% | -33.74% | -53.74% |
| Canton Strategic Holdings Inc (CNTN)vs › | $180.47M | -9.57% | -477.38% | -295.61% | -295.61% |
| AN2 Therapeutics, Inc. (ANTX)vs › | $182.60M | -51.01% | -69.12% | -59.60% | -89.29% |
| Yarrow Bioscience Inc (YARW)vs › | $174.27M | -90.33% | -95.47% | -83.14% | -82.51% |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.76M | -42.61% | -32.20% | -32.84% | -32.70% |
| Organogenesis Holdings Inc. (ORGO)vs › | $172.42M | -8.34% | 4.10% | 3.63% | 7.54% |
| Precision BioSciences, Inc. (DTIL)vs › | $171.13M | -30.23% | -28.70% | -31.34% | -41.69% |
| Journey Medical Corporation (DERM)vs › | $169.53M | -5.22% | -22.12% | -29.09% | -27.39% |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $189.11M | -74.02% | -48.91% | -62.69% | -47.07% |
ROIC
-3.2%
ROE
55.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -3.21% |
| 2026-03-31 | -4.60% |
| 2025-12-31 | -6.05% |
| 2025-09-30 | -4.76% |
| 2025-06-30 | -8.64% |
| 2025-03-31 | -10.07% |
| 2024-12-31 | -8.54% |
| 2024-09-30 | -5.01% |
| 2024-06-30 | -6.61% |
| 2024-03-31 | -6.69% |
| 2023-12-31 | -7.22% |
| 2023-09-30 | -9.48% |
| 2023-06-30 | -17.35% |
| 2023-03-31 | -22.32% |
| 2022-12-31 | -26.04% |
| 2021-11-30 | -15.14% |
| 2021-08-31 | -19.97% |
| 2021-05-31 | -26.53% |
| 2021-02-28 | -28.69% |
| 2020-11-30 | -43.02% |
| 2020-08-31 | -29.32% |
| 2020-05-31 | -26.38% |
| 2020-02-29 | -52.13% |
| 2019-11-30 | -46.78% |
| 2019-08-31 | -49.84% |
| 2019-05-31 | -47.91% |
| 2019-02-28 | -43.30% |
| 2018-11-30 | -39.15% |
| 2018-08-31 | -31.57% |
| 2018-05-31 | -45.59% |
| 2018-02-28 | -32.36% |
| 2017-11-30 | -30.49% |
| 2017-08-31 | -32.11% |
| 2017-05-31 | -32.96% |
| 2017-02-28 | -30.92% |
| 2016-11-30 | -24.78% |
| 2016-08-31 | -25.53% |
| 2016-05-31 | -24.72% |
| 2016-02-29 | -22.16% |
| 2015-11-30 | -35.12% |
| 2015-08-31 | -29.69% |
| 2015-05-31 | -32.11% |
| 2015-02-28 | -31.86% |
| 2014-11-30 | -27.98% |
| 2014-08-31 | -28.35% |
| 2014-05-31 | -23.79% |
| 2014-02-28 | -19.97% |
| 2013-11-30 | -64.61% |
| 2013-08-31 | -52.73% |
| 2013-05-31 | 34.19% |
| 2013-02-28 | 41.88% |
| 2012-11-30 | 40.34% |
| 2012-08-31 | 62.02% |
| 2012-05-31 | -119.98% |
| 2012-02-29 | -101.26% |
| 2011-11-30 | -66.11% |
| 2011-08-31 | -62.69% |
| 2011-05-31 | -65.11% |
| 2011-02-28 | -96.55% |
| 2010-11-30 | -302.90% |
| 2010-08-31 | -299.56% |
| 2010-05-31 | -121.32% |
| 2010-02-28 | -86.62% |
| 2009-11-30 | -86.30% |
| 2009-08-31 | -96.23% |
| 2009-05-31 | -121.49% |
| 2009-02-28 | -119.97% |
| 2008-11-30 | -95.83% |
| 2008-08-31 | -58.07% |
| 2008-05-31 | -876.85% |
| 2008-02-29 | -534.44% |
| 2007-11-30 | -361.20% |
| 2007-08-31 | -397.46% |
